<DOC>
	<DOC>NCT00524641</DOC>
	<brief_summary>To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6 weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.</brief_summary>
	<brief_title>Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Asthma patients from both sexes, age 18 or older Have already been on Symbicort SMART treatment Willing to give written informed consents to participate in the program. Patients who are not willing to give written informed consent Patients in emergency care for asthma at ICUs or COPD patients are excluded from the program.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Symbicort</keyword>
	<keyword>NIS</keyword>
</DOC>